Fig 2: Low RBM10 expression is associated with poor prognosis in LUAD.

Fig 3: Evidence of inverse regulation of RBM10 by miR-224-5p.

Fig 4: miR-224-5p promoted A549 proliferation and migration in vitro by targeting RBM10.

Fig 5: miR-224-5p promotes LUAD tumor growth in vivo by targeting RBM10.